Loading…
Lobbying Spend
—
Filings
74
Firms Hired
1
Active Period
2007–2025
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Improving Access to Medicare Coverage Act of 2017
2018 · fourth_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
Changes to Medicare Observation Stay requirements (HR 1421 & S 568). Changes to 340B drug program (HR 4392).
Client expense: — · Firm income: $6,000
Matched citations: HR 1421
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
2018 · fourth_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
Changes to Medicare Observation Stay requirements (HR 1421 & S 568). Changes to 340B drug program (HR 4392).
Client expense: — · Firm income: $6,000
Matched citations: HR 4392
Improving Access to Medicare Coverage Act of 2017
2018 · fourth_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
Changes to Medicare Observation Stay requirements (HR 1421 & S 568). Changes to 340B drug program (HR 4392).
Client expense: — · Firm income: $6,000
Matched citations: S 568
Improving Access to Medicare Coverage Act of 2017
2018 · third_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
Changes to Medicare Observation Stay requirements (HR 1421 & S 568). Changes to 340B drug program (HR 4392).
Client expense: — · Firm income: $6,000
Matched citations: HR 1421
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
2018 · third_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
Changes to Medicare Observation Stay requirements (HR 1421 & S 568). Changes to 340B drug program (HR 4392).
Client expense: — · Firm income: $6,000
Matched citations: HR 4392
Improving Access to Medicare Coverage Act of 2017
2018 · third_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
Changes to Medicare Observation Stay requirements (HR 1421 & S 568). Changes to 340B drug program (HR 4392).
Client expense: — · Firm income: $6,000
Matched citations: S 568
Improving Access to Medicare Coverage Act of 2017
2018 · second_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
Changes to Medicare Observation Stay requirements (HR 1421 & S 568). Changes to 340B drug program (HR 4392).
Client expense: — · Firm income: $6,000
Matched citations: HR 1421
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
2018 · second_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
Changes to Medicare Observation Stay requirements (HR 1421 & S 568). Changes to 340B drug program (HR 4392).
Client expense: — · Firm income: $6,000
Matched citations: HR 4392
Improving Access to Medicare Coverage Act of 2017
2018 · second_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
Changes to Medicare Observation Stay requirements (HR 1421 & S 568). Changes to 340B drug program (HR 4392).
Client expense: — · Firm income: $6,000
Matched citations: S 568
Improving Access to Medicare Coverage Act of 2017
2018 · first_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
Changes to Medicare Observation Stay requirements (HR 1421 & S 568). Changes to 340B drug program (HR 4392).
Client expense: — · Firm income: $6,000
Matched citations: HR 1421
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
2018 · first_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
Changes to Medicare Observation Stay requirements (HR 1421 & S 568). Changes to 340B drug program (HR 4392).
Client expense: — · Firm income: $6,000
Matched citations: HR 4392
Improving Access to Medicare Coverage Act of 2017
2018 · first_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
Changes to Medicare Observation Stay requirements (HR 1421 & S 568). Changes to 340B drug program (HR 4392).
Client expense: — · Firm income: $6,000
Matched citations: S 568
Emergency Retiree Health Benefits Protection Act of 2009
2009 · fourth_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
HR 1322
Client expense: — · Firm income: $18,750
Matched citations: HR 1322
Medicare Recovery Audit Contractor Program Moratorium Act of 2007
2008 · third_quarter · Firm: MILLER & WENHOLD CAPITOL STRATEGIES
H.R. 4105 - CMS RAC Audit legislation
Client expense: — · Firm income: $12,000
Matched citations: H.R. 4105
Source: Senate LDA